Diseases, Conditions, Syndromes

Antithrombotic therapy not helpful for COVID-19 outpatients

(HealthDay)—Compared with placebo, neither aspirin nor apixaban reduces the rate of major adverse cardiovascular or pulmonary outcomes for clinically stable outpatients with symptomatic COVID-19, according to a study published ...

Cardiology

SGLT2 inhibitors may cut risk for heart failure hospitalization

(HealthDay)—For patients with type 2 diabetes (T2D), with or without cardiovascular disease (CVD), use of sodium-glucose cotransporter-2 (SGLT2) inhibitors compared with glucagon-like peptide-1 receptor agonists (GLP-1 ...

Cardiology

Flu jab after heart attack should become standard care

Influenza vaccination reduces the risk of all-cause death, myocardial infarction, or stent thrombosis at 12 months in hospitalized patients with myocardial infarction or high-risk coronary disease, according to late breaking ...

page 25 from 40